Clinically Significant Thromboembolic Disease in Adult Spinal Deformity Surgery: Incidence and Risk Factors in 737 Patients.

Kim, Han Jo; Iyer, Sravisht; Diebo, Basel G; Kelly, Michael P; Sciubba, Daniel; Schwab, Frank; Lafage, Virginie; Mundis, Gregory M et al. · Global Spine J · 2018

retrospective_cohort · Level III

Where this comes from

Abstract

Retrospective cohort study. Describe the rate and risk factors for venous thromboembolic events (VTEs; defined as deep venous thrombosis [DVT] and/or pulmonary embolism [PE]) in adult spinal deformity (ASD) surgery. ASD patients with VTE were identified in a prospective, multicenter database. Complications, revision, and mortality rate were examined. Patient demographics, operative details, and radiographic and clinical outcomes were compared with a non-VTE group. Multivariate binary regression model was used to identify predictors of VTE. A total of 737 patients were identified, 32 (4.3%) had VTE (DVT = 14; PE = 18). At baseline, VTE patients were less likely to be employed in jobs requiring physical labor (59.4% vs 79.7%, <i>P</i> < .01) and more likely to have osteoporosis (29% vs 15.1%, <i>P</i> = .037) and liver disease (6.5% vs 1.4%, <i>P</i> = .027). Patients with VTE had a larger preoperative sagittal vertical axis (SVA; 93 mm vs 55 mm, <i>P</i> < .01) and underwent larger SVA corrections. VTE was associated with a combined anterior/posterior approach (45% vs 25%, <i>P</i> = .028). VTE patients had a longer hospital stay (10 vs 7 days, <i>P</i> < .05) and higher mortality rate (6.3% vs 0.7%, <i>P</i> < .01). Multivariate analysis demonstrated osteoporosis, lack of physical labor, and increased SVA correction were independent predictors of VTE (<i>r</i><sup>2</sup> = .11, area under the curve = 0.74, <i>P</i> < .05). The incidence of VTE in ASD is 4.3% with a DVT rate of 1.9% and PE rate of 2.4%. Osteoporosis, lack of physical labor, and increased SVA correction were independent predictors of VTE. Patients with VTE had a higher mortality rate compared with non-VTE patients.